ES2063135T3 - Composiciones para el relleno de heridas. - Google Patents

Composiciones para el relleno de heridas.

Info

Publication number
ES2063135T3
ES2063135T3 ES89308009T ES89308009T ES2063135T3 ES 2063135 T3 ES2063135 T3 ES 2063135T3 ES 89308009 T ES89308009 T ES 89308009T ES 89308009 T ES89308009 T ES 89308009T ES 2063135 T3 ES2063135 T3 ES 2063135T3
Authority
ES
Spain
Prior art keywords
compositions
wounds
citosan
filling
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308009T
Other languages
English (en)
Inventor
Deral T C O Minnesota M Mosbey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of ES2063135T3 publication Critical patent/ES2063135T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICIONES PARA OBTURAR HERIDAS QUE CONTIENEN: A) CITOSAN; B) POR LO MENOS UN MATERIAL HIDROCOLOIDE COMPATIBLE DISTINTO DEL CITOSAN, Y C) AGUA, TIENEN VARIAS PROPIEDADES DESEABLES PARA USAR EN OBTURACION DE HERIDAS GRANDES, TALES COMO ULCERAS DERMICAS, SIN QUE PRESENTEN SINERESIS. LAS COMPOSICIONES PREFERIDAS TIENEN ACTIVIDAD ANTIMICROBIANA, CAPACIDAD PARA TAPONAR HERIDAS, UNA VISCOSIDAD ADECUADA QUE LAS HACE APLICABLES A, Y PERMANECER EN, UNA HERIDA ABIERTA, Y PUEDEN ABSORBER REZUMADO DE UNA HERIDA.
ES89308009T 1988-08-18 1989-08-07 Composiciones para el relleno de heridas. Expired - Lifetime ES2063135T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/233,560 US4956350A (en) 1988-08-18 1988-08-18 Wound filling compositions

Publications (1)

Publication Number Publication Date
ES2063135T3 true ES2063135T3 (es) 1995-01-01

Family

ID=22877731

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308009T Expired - Lifetime ES2063135T3 (es) 1988-08-18 1989-08-07 Composiciones para el relleno de heridas.

Country Status (6)

Country Link
US (1) US4956350A (es)
EP (1) EP0356060B1 (es)
JP (1) JPH02107267A (es)
AU (1) AU627204B2 (es)
DE (1) DE68918538T2 (es)
ES (1) ES2063135T3 (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675535A5 (es) * 1988-11-28 1990-10-15 Nestle Sa
JP2648886B2 (ja) * 1990-10-30 1997-09-03 日本曹達株式会社 家蓄の乳房炎を予防する方法
EP0596215A1 (en) * 1992-11-02 1994-05-11 Sunfive Company Ltd Applying material for protecting wound surface
GB9421969D0 (en) * 1994-10-28 1994-12-21 Innovative Tech Ltd Wound treatment composition
US5599916A (en) * 1994-12-22 1997-02-04 Kimberly-Clark Corporation Chitosan salts having improved absorbent properties and process for the preparation thereof
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
WO1997007139A2 (en) * 1995-08-17 1997-02-27 Novartis Ag Stabilized chitin derivative compounds
GB9609474D0 (en) * 1996-05-08 1996-07-10 Innovative Tech Ltd Hydrogels
US5836970A (en) * 1996-08-02 1998-11-17 The Kendall Company Hemostatic wound dressing
GB2322864A (en) 1997-03-07 1998-09-09 Polybiomed Ltd Gel for application to the human or animal body
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
WO2000030609A1 (en) * 1998-11-20 2000-06-02 Laboratoire Medidom S.A. Aqueous ophthalmic formulations comprising chitosan
WO2001036000A1 (en) 1999-11-15 2001-05-25 Bio Syntech Canada, Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
ATE243049T1 (de) * 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US6566575B1 (en) 2000-02-15 2003-05-20 3M Innovative Properties Company Patterned absorbent article for wound dressing
US7137968B1 (en) 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
EP1274472A2 (en) 2000-03-20 2003-01-15 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
KR20010100252A (ko) * 2000-03-29 2001-11-14 임창준 수용성 키토산 막의 제조방법 및 그를 이용한 일회용 밴드
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
NZ523763A (en) * 2000-06-29 2005-02-25 Biosyntech Canada Inc Compostion and method for the repair and regeneration of cartilage and other tissues
AU2001287628A1 (en) * 2000-07-17 2002-01-30 Hansa Medical Ab Antimicrobial agent
ES2231528T3 (es) 2000-07-27 2005-05-16 Nucryst Pharmaceuticals Corp. Utilizacion de metales nobles para la fabricacion de un medicamento para el tratamientyo de trastornos y enfermedades cutaneas hiperproliferativas.
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
AU2002221370A1 (en) * 2000-11-15 2002-05-27 Bio Syntech Canada Inc Method for restoring a damaged or degenerated intervertebral disc
DE60210441T2 (de) 2001-04-23 2006-11-16 Nucryst Pharmaceuticals Corp., Fort Saskatchewan Arzneimittel oder pflaster enthaltend ein metall wie silber, gold, platin oder palladium als antimikrobiellen wirkstoff und dessen verwendung in der behandlung von hautentzündungen
US20060004314A1 (en) * 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
US8741335B2 (en) * 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US7371403B2 (en) * 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US7482503B2 (en) 2001-06-14 2009-01-27 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
JP3947391B2 (ja) * 2001-11-28 2007-07-18 独立行政法人 日本原子力研究開発機構 橋かけ構造を有するキチン誘導体及び／又はキトサン誘導体の製造方法
US7201925B2 (en) 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
US8269058B2 (en) 2002-06-14 2012-09-18 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20070082023A1 (en) * 2002-06-14 2007-04-12 Hemcon Medical Technologies, Inc. Supple tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20050137512A1 (en) * 2003-12-23 2005-06-23 Campbell Todd D. Wound dressing and method for controlling severe, life-threatening bleeding
CA2493083C (en) * 2002-07-16 2012-11-06 Bio Syntech Canada Inc. Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
CN100453121C (zh) * 2002-11-12 2009-01-21 吴奕光 一种医用敷料及其生产方法
DE602004030264D1 (de) 2003-09-12 2011-01-05 Z Medica Corp Teilweise hydriertes hämostatisches mittel
EP1663090A4 (en) 2003-09-12 2010-07-21 Z Medica Corp HEMOSTATIC AGENT OF CALCIUM ZEOLITE
US8173171B2 (en) * 2003-11-17 2012-05-08 Taiwan Textile Research Institute Hydrogel microparticle composition, application thereof and method for preparing the same
TW200517128A (en) * 2003-11-17 2005-06-01 China Testile Inst Micro-particles of hydrogel containing polysaccharide or its derivatives composition and method for preparing the same
RU2240830C1 (ru) * 2003-12-26 2004-11-27 ФГУП Государственный научно-исследовательский институт особо чистых биопрепаратов Раневое покрытие и способ его получения
WO2005107710A2 (en) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
US20060178609A1 (en) 2005-02-09 2006-08-10 Z-Medica, Llc Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
CA2597940A1 (en) 2005-02-15 2006-08-24 Virginia Commonwealth University Mineral technologies (mt) for acute hemostasis and for the treatment of acute wounds and chronic ulcers
US9204957B2 (en) * 2005-03-17 2015-12-08 Hemcon Medical Technologies, Inc. Systems and methods for hemorrhage control and or tissue repair
US9326995B2 (en) 2005-04-04 2016-05-03 The Regents Of The University Of California Oxides for wound healing and body repair
US20060282046A1 (en) * 2005-04-13 2006-12-14 Horn Jeffrey L Device and method for subcutaneous delivery of blood clotting agent
WO2007051311A1 (en) * 2005-11-04 2007-05-10 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
US8938898B2 (en) 2006-04-27 2015-01-27 Z-Medica, Llc Devices for the identification of medical products
CA2653175A1 (en) * 2006-05-23 2007-12-06 Providence Health System-Oregon D/B/A Providence St. Vincent Medical Cen Ter Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7968114B2 (en) 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US20070276308A1 (en) * 2006-05-26 2007-11-29 Huey Raymond J Hemostatic agents and devices for the delivery thereof
WO2009085651A1 (en) 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Metal carbonate particles for use in medicine and methods of making thereof
AU2009241687A1 (en) * 2008-05-02 2009-11-05 Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center Wound dressing devices and methods
EP2340002B1 (en) 2008-10-06 2015-03-25 Providence Health System - Oregon Foam medical devices and methods
WO2010109432A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi An antiscabies medicinal cream and a process to make it
EP2394670A1 (en) 2010-06-04 2011-12-14 Université de Liège Chitosan-based biomimetic scaffolds and methods for preparing the same
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
KR20140090670A (ko) * 2011-11-13 2014-07-17 수네리스 인코포레이티드 인시츄 가교결합성 중합체 조성물 및 그 방법
CA3183404A1 (en) 2012-06-22 2013-12-27 Teleflex Life Sciences Limited Hemostatic devices
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
ES2921990T3 (es) 2014-09-10 2022-09-05 Bard Inc C R Apósito protector para un dispositivo médico colocado en la piel
WO2018108256A1 (en) 2016-12-13 2018-06-21 Stahl Kurt Wilhelm Composition for dressing cutaneous lesions and manufacturing method thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903268A (en) * 1968-02-12 1975-09-02 Lescarden Ltd Chitin and chitin derivatives for promoting wound healing
JPS5684701A (en) * 1979-12-14 1981-07-10 Kohjin Co Ltd Production of absorbing material
US4394373A (en) * 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
US4501835A (en) * 1982-03-08 1985-02-26 Polaroid Corporation Polyacrylic acid/chitosan polyelectrolyte complex
US4570629A (en) * 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
CA1213520A (en) * 1982-03-17 1986-11-04 Abe Widra Hydrophilic biopolymeric copolyelectrolytes, and biodegradable dressings comprising same
US4538603A (en) * 1982-04-22 1985-09-03 E. R. Squibb & Sons, Inc. Dressings, granules, and their use in treating wounds
US4605623A (en) * 1982-11-08 1986-08-12 Malette William Graham Method of altering growth and development and suppressing contamination microorganisms in cell or tissue culture
CA1202904A (en) * 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
EP0152898B1 (en) * 1984-02-15 1990-01-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system(
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
JPS6173665A (ja) * 1984-09-20 1986-04-15 熊部　潔 人工皮膜による傷口の保護方法
JPS61135519A (ja) * 1984-12-05 1986-06-23 旭化成株式会社 果樹支持用線条体
EP0187703B1 (en) * 1985-01-11 1992-08-05 Teijin Limited Sustained release preparation

Also Published As

Publication number Publication date
AU627204B2 (en) 1992-08-20
JPH02107267A (ja) 1990-04-19
EP0356060B1 (en) 1994-09-28
US4956350A (en) 1990-09-11
AU3933689A (en) 1990-02-22
EP0356060A2 (en) 1990-02-28
DE68918538T2 (de) 1995-04-20
EP0356060A3 (en) 1990-10-10
DE68918538D1 (de) 1994-11-03

Similar Documents

Publication Publication Date Title
ES2063135T3 (es) Composiciones para el relleno de heridas.
ES2059738T3 (es) Composicion adhesiva de hidrocoloide.
US2714382A (en) Emergency bandages
PE23797A1 (es) Una estructura absorbente elastomerica
ES2118246T3 (es) Banda polimerica con secciones deformadas que proporcionan a la banda una elasticidad sustancialmente incrementada.
ES2061019T3 (es) Vendaje elastico tejido o de punto.
GB2194446B (en) Wound dressing, its preparation and use
ECSP055840A (es) Derivados de 4 -tetrazolil-4fenilpiperidina para el tratamiento del dolor
AR021371A1 (es) Aposito
AR021857A1 (es) Un articulo absorbente para la higiene personal tipo vendaje para heridas, el material absorbente que lo comprende y un dispositivo catamenial quecomprende dicho material
BRPI0514116A (pt) artigos absorventes compreendendo um agente modificador de exsudado corpóreo e uma formulação para cuidado da pele
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
ES488331A0 (es) Dispositivo mejorado para el tratamiento intensivo de liqui-dos tales como aguas residuales, en particular para la puri-ficacion de los mismos
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
AR226835A1 (es) Composiciones insecticidas y acaricidas que contienen compuestos antibioticos,utiles para la proteccion de plantas,con exclusion de su uso en seres humanos y animales superiores;nuevos compuestos antibioticos contenidos en dichas composiciones,y procedimiento para producirlos
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
JPS5426336A (en) Makeup base composition
AR247068A1 (es) Composicion antimicrobiana y metodo de aplicacion.
AR228138A1 (es) Composiciones para combatir infecciones por hongos en plantas utiles,conteniendo n-aril-n-acil-3-amino-oxazolidin-2-onas como compuesto activo,procedimiento para preparar a estos ultimos y nuevas n-aril-n-acil-3-amino-oxazolidin-2-onas utilizadas en dichas composiciones
SE8605044L (sv) Komposition for utvertes bruk
JPS54156393A (en) Tampon for medical treatment* sanitation* beauty culture* etc*
ES2041687T3 (es) Composicion insecticida para un fumigador electrico.
ES2133360T3 (es) Procedimiento para reducir la insaturacion en polioles.
JPS53101540A (en) Skin cosmetics
AR016200A1 (es) El uso de una composicion que comprende uno o mas compuestos que contienen azufre para la fabricacion de un medicamento para aumentar la permeabilidad deltejido corneo humano, y un kit que incluye dicha composicion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 356060

Country of ref document: ES